Literature DB >> 8119106

Distinct electroretinographic oscillatory potential generators as revealed by field distribution.

F Tremblay1, S R Lam.   

Abstract

Oscillatory potentials (OPs) of the electroretinographic signal were recorded in five healthy subjects by means of dermal electrodes located at various positions along the infraorbital ridge and referred to either a frontal or a temporal electrode. Flashes of light were generated in a Ganzfeld stimulator, and OPs were recorded with the subjects' eyes in abduction and adduction. This arrangement of eyeball and electrode positions makes it possible to record the retinal activity from various axes; from a pupillary-posterior pole (longitudinal) axis to an equatorial axis. The individual OPs were found to be selectively affected by the axis of recording, thus suggesting distinct sources of generation. All the OPs reversed in polarity as the recording axis maintained by the electrodes was moved from the longitudinal to the transverse axis. The point of inversion of OP2 and OP3 was similar, as was their amplitude ratio (OP3/OP2), which remained independent of the eye position. However, OP4 became inverted at a different location, closer to the longitudinal axis, and the amplitude ratio (OP4/OP2) varied significantly with the eye position. Altogether, these results suggest different retinal source generators for OP2 and OP3, and for OP4.

Entities:  

Mesh:

Year:  1993        PMID: 8119106     DOI: 10.1007/bf01203660

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  18 in total

1.  The postnatal development of the oscillatory potentials of the electroretinogram. I. Basic characteristics.

Authors:  M el-Azazi; L Wachtmeister
Journal:  Acta Ophthalmol (Copenh)       Date:  1990-08

2.  Evidence for an intensity-coding oscillatory potential in the human electroretinogram.

Authors:  P Lachapelle
Journal:  Vision Res       Date:  1991       Impact factor: 1.886

3.  The effect of a slow flicker on the human photopic oscillatory potentials.

Authors:  P Lachapelle
Journal:  Vision Res       Date:  1991       Impact factor: 1.886

4.  Measuring oscillatory potentials: Fourier analysis.

Authors:  K Van der Torren; G Groeneweg; G van Lith
Journal:  Doc Ophthalmol       Date:  1988-06       Impact factor: 2.379

5.  Human ERG in response to double flashes of light during the course of dark adaptation: a Fourier analysis of the oscillatory potentials.

Authors:  P Algvere; S Westbeck
Journal:  Vision Res       Date:  1972-02       Impact factor: 1.886

6.  Origin of the oscillatory potentials in the primate retina.

Authors:  H Heynen; L Wachtmeister; D van Norren
Journal:  Vision Res       Date:  1985       Impact factor: 1.886

7.  Oscillatory potentials as a marker for dopaminergic disease.

Authors:  M F Marmor; P Hock; G Schechter; A Pfefferbaum; P A Berger; R Maurice
Journal:  Doc Ophthalmol       Date:  1988-07       Impact factor: 2.379

8.  Further studies of the chemical sensitivity of the oscillatory potentials of the electroretinogram (ERG). II. Glutamate-aspartate-and dopamine antagonists.

Authors:  L Wachtmeister
Journal:  Acta Ophthalmol (Copenh)       Date:  1981-04

9.  Maturation of the photopic b-wave and oscillatory potentials of the electroretinogram in the neonatal rabbit.

Authors:  J Gorfinkel; P Lachapelle
Journal:  Can J Ophthalmol       Date:  1990-04       Impact factor: 1.882

10.  Oscillatory potentials in early diabetic retinopathy.

Authors:  K van der Torren; G van Lith
Journal:  Doc Ophthalmol       Date:  1989-04       Impact factor: 2.379

View more
  2 in total

1.  Alteration of electroretinographic recordings when performed under sedation or halogenate anesthesia in a pediatric population.

Authors:  François Tremblay; Joan E Parkinson
Journal:  Doc Ophthalmol       Date:  2003-11       Impact factor: 2.379

2.  Oscillatory potentials with repeated-flash electroretinography.

Authors:  Kazuki Kuniyoshi; Motohiro Irifune; Naoki Uno; Akira Nakao; Yoshikazu Shimomura
Journal:  Jpn J Ophthalmol       Date:  2010-02-12       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.